Option chain shows key data for Xeris Biopharma Holdings's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Xeris Biopharma Holdings.

Xeris Biopharma Holdings (NASDAQ:XERS) Stock, Option Chain

Xeris Biopharma Holdings

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BFLY

LWAY

SKYH

SPNS

XERS

Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Penny stock: gli insider muovono il mercato con acquisti strategici

Long Ideas

Penny Stocks

Insider Trades

BCOV

PGEN

More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying

STKS

Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings Inc

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587635585064ed0001400105/michael-blum">Wells Fargo analyst Michael Blum </a>initiated coverage on GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with an Overweight rating and announced a price target of $385. GE Vernova shares closed at $342.77 on Wednesday. <a href="https://www.benzinga.com/quote/GEV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer analyst Michael Phillips initiated coverage on International General Insurance Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) with an Outperform rating and announced a price target of $30. Intl General Insurance shares closed at $24.54 on Wednesday. <a href="https://www.benzinga.com/quote/IGIC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel analyst Lars Kjellberg initiated coverage on Mativ Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATV#NYSE">MATV</a>) with a Hold rating and announced a price target of $15.5. Mativ shares closed at $12.52 on Wednesday. <a href="https://www.benzinga.com/quote/MATV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs analyst Richard Law initiated coverage on Merus N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) with a Buy rating and announced a price target of $73. Merus shares closed at $42.93 on Wednesday. <a href="https://www.benzinga.com/quote/MRUS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS analyst A.J. Rice initiated coverage on The Ensign Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) with a Buy rating and announced a price target of $175. Ensign Group shares closed at $144.66 on Wednesday. <a href="https://www.benzinga.com/quote/ENSG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying GEV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="578" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21132522/image-224-1024x578.png" alt="" class="wp-image-659530" style="width:710px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21132522/image-224-1024x578.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21132522/image-224-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21132522/image-224-768x434.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21132522/image-224.png 1190w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Initiation

Analyst Ratings

ENSG

IGIC

MATV

MRUS

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Airbnb (ABNB) is sitting in a wide range into its next earnings cycle in February and it seems reasonable that the price action might stay in that range.
Here's the best trade to profit from that.
The trade we're looking at today is a short iron condor expiring in January, 2025. Currently, ABNB's relative resistance zone sits right around $150, and relative support is near $330. So we want a trade that makes us money as long as ABNB shares stay in that $150-$330 range.
With that in mind, our short iron condor, a combination of a short call spread and a short put spread, looks like this:
<ul>
<li>Sell to open 1 ABNB 17 Jan 150 calls</li>
<li>Buy to open 1 ABNB 17 Jan 155 calls</li>
<li>Buy to open 1 ABNB 17 Jan 330 puts</li>
<li>Sell to open 1 ABNB 17 Jan 320 puts</li>
</ul>
The short iron condor yields maximum profit when the share price of the underlying stock is equal to or between the strike prices of the "short" options (the ones you sell to open) on the day they expire.
In other words, as long as shares of Airbnb trade between $150 and $320, this trade will yield its maximum profit. The total potential profit what we collect on the credit side which is $1.26 at this writing and the total risk is difference between the distance of the strikes and the credit collected ($5 &#8211; $1.26= $3.74).
People often ask why they should use a short iron condor when the risk is so much higher than the reward, and that answer comes to probabilities. The probability the prices move into our short strikes is currently 15% while the probability that we hold outside this region is 85%.
The strategy result provides only two choices to exit the trade:
<ol>
<li>To buy back the short iron condor when it is performing at your target parameters. I like the 50% profit range.</li>
<li>To buy back the short iron condor when it hits either of the short strikes or hits the loss threshold that is desirable for you. Again, I like the 50% stop here.</li>
</ol>
Our new &#8220;Perfect Stock&#8221; Portfolio brings you a carefully selected lineup of value stocks, built to deliver market-beating performance. Take control of your portfolio with expert picks focused on growth and stability.  <a href="https://www.benzinga.com/premium/ideas/perfect-portfolio/?utm_source=WebRD-1121">Click to get access now.</a>
Image via Shutterstock

Opinion

How to Profit From Airbnb's "Stuck" Share Price

WIIM

CDTX

Cidara Therapeutics shares are trading higher. The company announced a $105 million private placement.

Investors with a lot of money to spend have taken a bullish stance on Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CELH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Celsius Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 66% bullish and 22%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $124,398, and 7 are calls, for a total amount of $683,710.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $40.0 for Celsius Holdings over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Celsius Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Celsius Holdings's substantial trades, within a strike price spectrum from $15.0 to $40.0 over the preceding 30 days.
<h3>Celsius Holdings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732213218_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.8</td>
<td>$5.65</td>
<td>$5.8</td>
<td>$40.00</td>
<td>$164.7K</td>
<td>3.6K</td>
<td align="right">414</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.15</td>
<td>$6.1</td>
<td>$6.15</td>
<td>$36.67</td>
<td>$156.2K</td>
<td>352</td>
<td align="right">6</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$15.25</td>
<td>$14.2</td>
<td>$14.75</td>
<td>$15.00</td>
<td>$147.5K</td>
<td>2</td>
<td align="right">100</td>
</tr>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$11.3</td>
<td>$11.2</td>
<td>$11.3</td>
<td>$37.50</td>
<td>$93.7K</td>
<td>501</td>
<td align="right">1</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$8.25</td>
<td>$8.05</td>
<td>$8.15</td>
<td>$27.50</td>
<td>$65.8K</td>
<td>237</td>
<td align="right">81</td>
</tr>
</tbody>
</table>

<h3>About Celsius Holdings</h3>
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
After a thorough review of the options trading surrounding Celsius Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Celsius Holdings</h3>
<ul>
<li>Currently trading with a volume of 3,116,776, the CELH's price is up by 2.53%, now at $28.41. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 98 days.</li>
</ul>
<h3>What The Experts Say On Celsius Holdings</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $44.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from B. Riley Securities persists with their Buy rating on Celsius Holdings, maintaining a target price of $44. 
&#x2A; Consistent in their evaluation, an analyst from Roth MKM keeps a Buy rating on Celsius Holdings with a target price of $40. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Celsius Holdings, targeting a price of $45. 
&#x2A; An analyst from Stifel persists with their Buy rating on Celsius Holdings, maintaining a target price of $45. 
&#x2A; Consistent in their evaluation, an analyst from B. Riley Securities keeps a Buy rating on Celsius Holdings with a target price of $47. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Celsius Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

CELH

What the Options Market Tells Us About Celsius Holdings

Deep-pocketed investors have adopted a bullish approach towards Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in WDAY usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Workday. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 66% leaning bullish and 33% bearish. Among these notable options, 2 are puts, totaling $244,664, and 7 are calls, amounting to $284,340.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $220.0 to $282.5 for Workday over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Workday's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Workday's whale activity within a strike price range from $220.0 to $282.5 in the last 30 days. 
<h3>Workday Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732213213_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/27/24</td>
<td>$2.2</td>
<td>$1.8</td>
<td>$1.9</td>
<td>$220.00</td>
<td>$189.0K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$1.75</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$220.00</td>
<td>$55.6K</td>
<td align="right">587</td>
<td align="right">275</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$10.3</td>
<td>$9.9</td>
<td>$10.2</td>
<td>$280.00</td>
<td>$50.9K</td>
<td align="right">751</td>
<td align="right">101</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$9.4</td>
<td>$9.1</td>
<td>$9.1</td>
<td>$280.00</td>
<td>$45.5K</td>
<td align="right">751</td>
<td align="right">51</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.0</td>
<td>$7.7</td>
<td>$7.9</td>
<td>$282.50</td>
<td>$42.6K</td>
<td align="right">1</td>
<td align="right">54</td>
</tr>
</tbody>
</table>

<h3>About Workday</h3>
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 18,000 employees.
After a thorough review of the options trading surrounding Workday, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Workday</h3>
<ul>
<li>With a volume of 937,628, the price of WDAY is up 1.34% at $262.92. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 5 days.</li>
</ul>
<h3>What The Experts Say On Workday</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $305.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Scotiabank lowers its rating to Sector Outperform with a new price target of $340. 
&#x2A; An analyst from Loop Capital persists with their Hold rating on Workday, maintaining a target price of $270. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Workday options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

WDAY

Looking At Workday's Recent Unusual Options Activity

LCID

RIVN

STLA

TSLA

Group Representing Major Automakers Urges President-Elect Trump To Preserve EV Tax, Production Tax Credits And Take Steps To Boost Self-Driving Vehicles

<a href="https://www.chicagofed.org/publications/speeches/2024/nov-21-central-indiana-corporate-partnership">https://www.chicagofed.org/publications/speeches/2024/nov-21-central-indiana-corporate-partnership</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Goolsbee Says Fed Relies On Economic Data That Is Forward-looking Like Inflation Expectations, But Will Not Speculate On Effect Of Policies That Are Predicted But Not In Place

Vertiv Holdings shares are trading higher in reaction to NVIDIA's recently announced strong financial results and guidance.

ANET

Arista Networks shares are trading higher in reaction to NVIDIA's recently announced strong financial results and guidance.

Idaho, the last U.S. state to legalize industrial hemp in April 2021, has significant potential to become a national leader in hemp cultivation. 
However, restrictive regulations are slowing the industry's growth, leaving farmers frustrated and cautious.
"Everyone&#8217;s nervous that it&#8217;s marijuana, or that it&#8217;s weed, or it&#8217;s a stepping stone to weed, but it&#8217;s a stepping stone to industrial building," said Triston Sponseller, one of Idaho's largest hemp farmers in an <a href="https://www.ktvb.com/article/news/agriculture/inside-ag/inside-ag-idaho-could-thrive-hemp-growing-giant-weed-out-restrictions/277-dd47e4aa-d290-476e-9f62-f9b11ab48790">article</a> by Hunter Frank on KTVB7. 
His operations in Roberts focus on <a href="https://www.benzinga.com/markets/cannabis/23/01/30577461/we-need-hemp-based-fiber-food-and-building-materials-not-just-cbd-says-industry-report">hemp fiber</a>, showcasing the crop's <a href="https://www.benzinga.com/markets/cannabis/24/08/40418137/industrial-hemps-14b-projected-growth-an-investment-opportunity-too-good-to-miss">industrial applications</a> rather than THC or CBD production.
<h3 class="wp-block-heading">Navigating Stringent Regulations</h3>
Idaho's hemp laws mandate that crops test below 0.3% THC. 
This year, Sponseller's crop tested at 0.8%, forcing him to remove seed heads and bear the cost. 
Like others, he used certified seeds that passed in other states but failed Idaho's stricter requirements. Under the state's "three strikes" rule, farmers exceeding THC limits three times in five years are banned from growing hemp for another five years.
"It was certified when it came from overseas, and it didn&#8217;t go hot in Colorado," Sponseller explained, emphasizing the challenges of complying with Idaho's rules. Testing and remediation costs further deter expansion. "I can&#8217;t grow 2,000 acres of hemp and afford 20, 30 different tests for each field," he added.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/01/30577461/we-need-hemp-based-fiber-food-and-building-materials-not-just-cbd-says-industry-report">We Need Hemp-Based Fiber, Food And Building Materials, Not Just CBD, Says Industry Report</a>
<h3 class="wp-block-heading">Promise Of Hemp In Idaho</h3>
Despite the hurdles, hemp farming in Idaho has quadrupled in acreage since 2022, according to the Idaho State Department of Agriculture (ISDA).
Farmers like Sponseller say they&#8217;re optimistic, pointing to hemp's versatility, water efficiency and benefits to soil health. At Sponseller's Rexburg facility, hemp stalks are processed into materials like insulation, paper, and landscaping products.
"For being a plant grown in a field, it&#8217;s impressive how strong it is; just its natural qualities," Sponseller said.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Call For Change</h3>
Idaho&#8217;s hemp cultivators plan to lobby lawmakers this winter to <a href="https://www.benzinga.com/markets/cannabis/24/09/40833963/expert-calls-for-a-united-hemp-and-cannabis-front-industries-should-collaborate-and-push-for-fed">ease regulations</a>, which could unlock hemp's potential to create jobs and boost the state&#8217;s economy. "Idaho has the highest restrictions in terms of remediation in probably most of the states in the U.S.," Sponseller said, noting that reforms could help farmers scale operations and attract manufacturing.
While progress is slow, he remains hopeful. "It&#8217;s new and it&#8217;s evolving, but it is moving forward." 
<h3 class="wp-block-heading">Proposed Farm Bill Changes </h3>
A recent new proposal from Senate Agriculture Chair Debbie Stabenow (D-Mich.) in the 2024 Farm Bill could significantly alter the regulatory landscape for hemp farmers, but in the opposite direction Sponseller is fighting for. 
Released Monday, the bill redefines THC regulations, replacing Delta-9 THC with total THC, explicitly including THC-A in the calculation. While maintaining the 0.3% THC threshold, the method for measurement is revised, creating a stricter environment for industrial hemp but preserving low-THC product pathways, such as CBD.
This change contrasts with the House Agriculture Committee&#8217;s version, which sought a complete ban on THC in hemp products. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/government/regulations/24/11/41851368/hemp-market-surge-how-new-regulations-could-impact-growth">Hemp Market Surge: How New Regulations Could Impact Growth</a></li>
</ul>
Cover: El Planteo.&nbsp;<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Cannabis

Government

Regulations

Can Idaho Lead The Hemp Industry? Only If Regulations Change

The outspoken economist, author and podcast host Peter Schiff has long been a lightning rod for debate. Known for his bold predictions and contrarian views, Schiff recently sat down with CEO.CA to discuss the U.S. economy, inflation and his ongoing criticism of Bitcoin. His perspective, as always, was sharp and unapologetically critical of current economic policies.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
The "Bubble Economy" Explained
Schiff argues that the U.S. economy has been in a bubble for decades. "What's been going on is that the government has been sustaining a bubble economy," Schiff stated. "It really took hold with Bush, reacting to the bursting of the dot-com bubble in 2001. Reckless policies have continued for over 20 years." According to Schiff, this pattern of debt-driven consumption has left the economy in an unsustainable state.
He elaborates that the Federal Reserve's monetary policies and unchecked fiscal deficits have propped up this bubble economy. "The whole economy is built on debt and consumption and it's going to implode because it's unsustainable," he said.
See Also: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence.&nbsp;</a>
Why Bitcoin Doesn't Make the Cut
Schiff's skepticism toward Bitcoin remains firm. He <a href="https://www.benzinga.com/personal-finance/24/08/40318568/mark-cuban-says-to-get-rich-invest-10-of-savings-in-high-risk-investments-but-if-its-bitcoin-thr">dismisses the cryptocurrency as "fool's gold</a>," designed to mimic some of gold's monetary properties but lacking its intrinsic value.
"People think that I don't own Bitcoin because I don't understand it," Schiff quipped. "No, I understand it precisely. That's why I don't own it. It's the people who own it that don't understand it – that's why they own it."
Schiff criticizes <a href="https://www.benzinga.com/general/24/03/37513063/warren-buffett-says-he-wouldnt-pay-25-for-all-the-bitcoin-in-the-world-he-considers-crypto-rat-poiso">Bitcoin for being nothing more than a speculative asset</a>. "The only money made is by transferring wealth from new buyers to old sellers," he claimed, calling it a classic pyramid scheme.
When pressed on what would make him change his mind, Schiff replied, "If Bitcoin actually replaces fiat currencies as a unit of account and a medium of exchange – if I walk into a supermarket and everything is priced in Bitcoin–I'd admit I was wrong. But it's no closer to being money today than it was when it started."
Gold and Silver: The Safer Bet
Schiff remains a <a href="https://www.benzinga.com/startups/24/08/40290032/robert-kiyosaki-believes-the-dollars-days-are-numbered-china-and-japan-are-trading-bonds-for-gold-he">steadfast advocate for gold and silver</a>, seeing them as the ultimate hedge against inflation. He noted that central banks are already increasing their gold reserves, signaling confidence in its long-term value.
"Gold is approaching record highs, but silver is still a bargain at around $33 an ounce," he said. Schiff believes silver could see significant gains in the years ahead, particularly as retail investors return.
He also encouraged investors to consider mining stocks, which he likened to "the next crypto," offering high returns without the speculative risks of digital currencies.
Trending: Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a>
What's Next for the U.S. Economy?
Schiff predicts that economic conditions will worsen before they improve, citing unsustainable debt levels and rising inflation. "It's going to get worse before it gets even worse," he said grimly, highlighting the government's inability to address underlying structural issues.
For those looking to safeguard their wealth, Schiff recommends diversifying portfolios into international stocks, emerging markets and commodities like energy and agriculture. His core message: get out of dollars and into tangible assets.
While Schiff's views often spark controversy, his arguments offer a sobering critique of the current economic landscape. Whether you agree or not, his warnings about inflation, unsustainable debt and speculative bubbles are worth considering. As Schiff says, "The key is to be <a href="https://www.benzinga.com/general/24/03/37513063/warren-buffett-says-he-wouldnt-pay-25-for-all-the-bitcoin-in-the-world-he-considers-crypto-rat-poiso">properly positioned before the collapse – </a>not after."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>
Image from Wikimedia

Peter Schiff Says Economic Bubble We're in Today Started 2 Decades Ago Under Bush – And 'It's Going To Get Worse Before It Gets Even Worse'

Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) announced plans to consolidate its domestic and international e-commerce operations into a single unit called Alibaba E-commerce Business Group.
The newly created division will be led by Jiang Fan, the current head of Alibaba International Digital Commerce, who has been the group&#8217;s CEO. He will report directly to Alibaba CEO Eddie Wu Yongming, SCMP <a target="_blank" href="https://www.scmp.com/tech/big-tech/article/3287583/alibaba-merge-domestic-and-global-e-commerce-units-names-jiang-fan-ceo" rel="noreferrer noopener">reports</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42111158/pdd-holdings-3-earnings-misses-expectations-reports-strong-transaction-growth-but-faces-challenges-in-competitive-market-shares-plunge" rel="noreferrer noopener">Temu Parent PDD Stock Tumbles After Q3 Profit Miss, Company Cites Intensified Competition and External Challenges</a>
The reorganization marks Alibaba&#8217;s most significant structural overhaul since the company split its operations into six independent business units in 2023.
This move is seen as a strategic effort to streamline operations and improve synergies between domestic and international supply chains, particularly as the company faces intensifying competition from rivals such as PDD Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), which has aggressively expanded globally with its shopping app Temu.
Jiang&#8217;s leadership in the international division has already demonstrated significant growth.
Alibaba has been actively realigning its business strategy under CEO Eddie Wu, who took over leadership in 2023.
Recent initiatives include launching a digital marketing tool, Quanzhantui, and implementing technology service fees for Taobao and Tmall merchants. These measures aim to revitalize its domestic operations while maintaining its global expansion trajectory.
During the recently concluded Singles&#8217; Day shopping festival, Taobao and Tmall accounted for roughly 50% of sales across major platforms, while Douyin led growth with a 19% increase in gross merchandise value.
Alibaba&nbsp;reported <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42006281/alibaba-q2-earnings-revenue-beats-forecast-cloud-and-international-sales-shine-free-cash-flow-falls-amid-strategic-investments" rel="noreferrer noopener">fiscal second-quarter 2024</a> revenue growth of 5% year-on-year to $33.70 billion, beating the analyst consensus of $33.47 billion.
Taobao and Tmall Group revenue grew by 1% to $14.11 billion. Alibaba International Digital Commerce Group revenue increased by 29% to $4.51 billion, driven by the growth of cross-border businesses.
Benchmark&#8217;s Fawne Jiang maintained a Buy rating on Alibaba with a price target of $118, <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42043480/alibabas-monetization-strategy-gains-momentum-but-gmv-growth-lags-analyst" rel="noreferrer noopener">citing mixed earnings performance</a>.
While customer management revenue grew 2.5% YoY, sluggish GMV growth and increased investments in Taobao and Tmall raise concerns over market share retention. The analyst expects improved monetization from software service fees and expanded Quanzhantui marketing use in upcoming quarters, aiding profitability. Fiscal 2025 revenue and EBITDA estimates were slightly reduced due to margin pressures but reflect confidence in the gradual recovery and user acquisition.
Price Action:&nbsp;BABA stock is down 0.99% at $85.91 at&nbsp;the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42113723/warner-music-group-q4-earnings-grows-revenue-and-margins-amid-streaming-challenges" target="_blank" rel="noreferrer noopener">Warner Music Q4 Earnings: Flat Digital Revenue Growth, Operating Cash Flow Falls</a></li>
</ul>
Photo Via Shutterstock

Emerging Markets

Tech

Media

BABA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Alibaba Reshapes E-Commerce Operations, Names Jiang Fan as Unit CEO

<a href="https://www.chicagofed.org/publications/speeches/2024/nov-21-central-indiana-corporate-partnership" title="https://www.chicagofed.org/publications/speeches/2024/nov-21-central-indiana-corporate-partnership">https://www.chicagofed.org/publications/speeches/2024/nov-21-central-indiana-corporate-partnership</a>

Fed's Goolsbee Says Neutral Is A Long Way Below Where Rates Are Now; Feels Like We Are Headed To 2% Inflation

Goldman Sachs analyst Brooke Roach reiterated the Buy rating on TJX Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) <a target="_blank" href="https://www.benzinga.com/quote/TJX/analyst-ratings" rel="noreferrer noopener">with a price forecast of $137.</a>
Yesterday, the company reported third-quarter earnings per share of $1.14 (+11%), <a target="_blank" href="https://www.benzinga.com/24/11/42088621/tjx-companies-beats-q3-earnings-stock-dips-on-dim-q4-outlook" rel="noreferrer noopener">beating the street view of $1.09</a>. Quarterly sales of $14.06 billion (+6%) beat the analyst consensus estimate of $13.95 billion.
TJX Companies reported a 3% increase in consolidated comparable store sales at the high end of the company&#8217;s plan, driven entirely by higher customer transactions.
Roach remains optimistic after the quarter, maintaining a &#8220;constructive view.&#8221;
The analyst is encouraged by TJX&#8217;s continued momentum in transaction-driven comparable sales across its various brands, as well as its strong execution in both new and existing categories.
Additionally, there is a promising long-term growth potential for TJX on a global scale.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42085436/target-q3-earnings-supply-chain-chaos-hits-bottomline-slashes-annual-profit-outlook-stock-tanks" rel="noreferrer noopener">Target Q3 Earnings: Supply Chain Chaos Hits Bottomline, Slashes Annual Profit Outlook, Stock Tanks</a>
The analyst sees further opportunities for the company to gain market share and expand margins, benefiting from stronger vendor relationships and improved merchandise margins. This positions TJX well to navigate short-term industry challenges, such as tariffs and freight costs, Roach adds.
The analyst noted that while there have been choppy trends across various sub-sectors of consumer discretionary during the third-quarter earnings season, Roach is particularly encouraged by TJX&#8217;s strong messaging regarding the home sector and early fourth-quarter growth momentum.
However, the analyst also pointed out that unseasonable weather and the impacts of hurricanes are expected to remain key topics as companies continue reporting quarterly results, with a particular focus on early holiday selling trends for off-price and department store competitors.
Price Action: TJX shares are trading lower by 0.29% to $119.47 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/42084907/nio-q3-earnings-11-6-gain-in-vehicle-deliveries-margins-improve-issues-robust-q4-delivery-outlook" target="_blank" rel="noreferrer noopener">NIO Q3 Earnings: 11.6% Gain In Vehicle Deliveries, Margins Improve, Issues Robust Q4 Delivery Outlook</a></li>
</ul>

Analyst Color

Equities

Reiteration

General

TJX Positioned For Market Share Gains: Analyst Notes Momentum In Sales And Margin Expansion

Luminar Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) shares are trading lower Thursday. The lidar company&#8217;s stock began trading on a split-adjusted basis. Here&#8217;s <a href="https://www.benzinga.com/quote/LAZR/news">what you need to know.</a>
What To Know: Luminar shareholders voted to approve a proposal regarding a reverse stock split at the end of October. On Nov. 13, Luminar&#8217;s board approved the reverse split at a ratio of 1-for-15. The split went into effect after the market close on Wednesday.
The reverse stock split was authorized by the company's board as part of a larger strategy to improve the company&#8217;s stock price and potentially attract more institutional investors. The adjusted shares began trading Thursday under the same ticker symbol: &#8220;LAZR.&#8221;
In addition to the reverse stock split, Luminar recently announced that it appointed Dominick Schiano as a new member of its board. Schiano, known for his experience in the automotive industry and as a dealmaker, is expected to contribute valuable strategic insights to the company. He will also join Luminar&#8217;s Audit Committee.
Luminar provided a <a href="https://www.benzinga.com/news/earnings/24/11/41888873/luminar-technologies-stock-is-rising-after-hours-whats-driving-the-action">business update</a> for the third quarter earlier this month. The lidar company said it shipped more product in the third quarter than it did in the past three quarters combined.
"Today nearly every major automaker has LiDAR planned into their roadmaps, and our commercial growth this quarter is a testament to both our technical leadership and ability to execute to global automaker standards," Luminar founder and CEO Austin Russell said in the company&#8217;s earnings release.
"This quarter, we've further restructured Luminar to withstand near-term headwinds facing the industry so we are better positioned to capitalize on the long-term value in this trillion-dollar industry."
LAZR Price Action: Luminar Technologies shares were down 6.24% at $10.68 at the time of publication Thursday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="528" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21115723/LAZR-1024x528.png" alt="" class="wp-image-659327" style="width:440px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21115723/LAZR-1024x528.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21115723/LAZR-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21115723/LAZR-768x396.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/21115723/LAZR.png 1176w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42118033/nba-legend-shaq-put-his-mom-and-dad-on-payroll-when-he-made-it-big-in-basketball-now-you-making-half-a-million-a-year">NBA Legend Shaq Put His Mom and Dad On Payroll When He Made It Big In Basketball – &#8216;Now You Making Half A Million A Year&#8217;</a></li>
</ul>
Photo: courtesy of Luminar.

Stock Split

LAZR

What's Going On With Luminar Technologies Stock Thursday?

<a href="https://qz.com/fda-peter-marks-rjk-vaccines-1851705107">https://qz.com/fda-peter-marks-rjk-vaccines-1851705107</a>
The U.S. Food and Drug Administration's (FDA) head of vaccine safety says that President-elect Donald Trump's embrace of vaccine skeptics could be an opportunity for the science community to teach the public about the value of these life-saving drugs. However, if these efforts fail it could lead to "natural consequences."
The FDA's Peter Marks made the remarks Thursday at the Jefferies London Healthcare Conference. Marks is the current director of the Center for Biologics Evaluation and Research (CBER) at the FDA. The center ensures the safety and effectiveness of biological products, including vaccines.
Marks said now is the chance for scientists to make the case for vaccines, as Trump has named noted anti-vaccine crusader Robert F. Kennedy Jr. as his pick to be the next Secretary of Health and Human Services.
Bloomberg is also reporting that Trump is likely to pick surgeon and public health researcher Marty Makary as the next head of the FDA. Previously, Makary has criticized the agency's approval of COVID-19 booster vaccines. Additionally, he has written several op-eds on the pandemic including one claiming that the U.S. would achieve <a href="https://www.wsj.com/articles/well-have-herd-immunity-by-april-11613669731">herd immunity by April 2021 </a>and a more recent one arguing that vaccines shouldn't be <a href="https://www.wsj.com/articles/biden-waves-another-covid-shot-through-fda-human-outcomes-data-195731c0">recommended universally</a> for lower-risk patients.
Marks said that if public health officials fail to make the case for vaccines there will be consequences.
"If that doesn't work, and everything runs wild in the opposite direction, just as your kids learn natural consequences — if you put your hand on a hot oven, you will get burned, et cetera, that kind of thing — the American public will learn the natural consequences of what happens if vaccination rates fall too far, because we will start to see measles, polio, things that we should never see in a well-developed country, come back," said Marks, who was speaking virtually at the conference, <a href="https://www.statnews.com/2024/11/21/peter-marks-fda-rfk-jr-vaccine-safety/">STAT reported</a>.
Marks said he expects a vigorous debate on COVID-19 vaccines and pediatric vaccines but hopes a "degree of moderation will prevail" on the topic of vaccines overall.

BNTX

MRNA

NVAX

Watching Shares Of Vaccine Stocks; Traders Circulate Article Titled "Top FDA vaccine official says RFK Jr. nomination is a chance for scientist to make the case for vaccines"

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is closing in on the $100,000 psychological milestone, backed by bullish chart patterns and <a href="https://www.benzinga.com/money/bitcoin-price-prediction">strong market fundamentals</a>.
What Happened: As Bitcoin clocked a new <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42109267/bitcoin-hits-new-all-time-high-above-98000-as-spot-etfs-crack-100-billion-net-asset-value-milestone">all-time high above $98,000</a>, analyst Ali Martinez says $100,000 may happen on Thursday, based on the apex crypto breaking out of a bull flag chart pattern.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> could reach $100,000 today as it appears to be breaking out of a bull flag on the lower timeframes. <a href="https://t.co/UKKcXilHO4">pic.twitter.com/UKKcXilHO4</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1859525723809067033?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Santiment data pointed out the collective holdings of whale and shark wallet as a key metric to watch, revealing an intriguing dynamic in whale and shark wallets that hold at least 10 BTC.
Over the last month, these wallets have <a href="https://x.com/santimentfeed/status/1859524090513547577">added</a> 56,397 BTC, worth approximately $5.43 billion. Despite this accumulation, the total number of such wallets dropped by 1,256 (-0.82%), signaling a possible consolidation among large holders.
Tracking these major stakeholders&#8217; movements will be key in understanding the sustainability of this historic bull rally.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42114012/bitcoin-price-hitting-100000-in-november-polymarket-traders-speculate-it-might-go-even-higher">Bitcoin Price Hitting $100,000 In November? Polymarket Traders Speculate It Might Go Even Higher</a>
Why It Matters:  According to IntoTheBlock, large transaction volumes and daily active addresses for Bitcoin have risen by 8.5% and 0.4%, respectively. 
Transactions exceeding $100,000 have jumped from 11,911 to 13,321 in a single day.
Coinglass data highlights that Bitcoin Futures open interest has reached a record $63.7 billion, underscoring heightened trader activity. 
Meanwhile, Bitcoin ETFs are <a href="https://x.com/BTC_Archive/status/1859588678206492967">closing</a> in on gold ETFs, with $104 billion in assets compared to gold&#8217;s $121 billion, achieved within just 11 months.
Price Action: 
Read Next: &nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42024635/scaramucci-trumps-crypto-support-could-push-bitcoin-to-150k">Scaramucci: Trump&#8217;s Crypto Support Could Push Bitcoin To $150K</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Close To $100,000 — Could It Happen Today?

Summit Materials shares are trading higher following a repot suggesting Quikrete is in talks to acquire the company.

Elon Musk and Vivek Ramaswamy are targeting lowering government spending with the newly announced Department of Government Efficiency (or D.O.G.E. for short). An aircraft component company is named as the perfect place for the duo to start in a new short report from <a href="https://www.benzinga.com/topic/the-bear-cave">The Bear Cave.</a>
What Happened: President-elect Donald Trump<a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently"> announced the Department of Government Efficiency</a> recently and Musk said the new department will "send shockwaves through the system, and involve anyone involved in government waste."
A short <a href="https://thebearcave.substack.com/p/problems-at-transdigm-tdg">report </a>from The Bear Cave author Edwin Dorsey suggests the D.O.G.E. should start with aircraft component company TransDigm (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>), which has a market capitalization of $72 billion.
The short report alleges TransDigm has used acquisitions to become the sole producer of some aircraft parts and in return raised prices for customers, which includes the Department of Defense.
Benzinga reached out to TransDigm for comment and did not hear back at publication.
"Prices for TransDigm parts have increased 40%+ per year for decades and the company has faced numerous allegations of price gouging the U.S. government as well as allegations of accounting fraud," Dorsey writes.
Dorsey said hints from Musk and Ramaswamy suggest looking at government waste at the Pentagon.
"The Bear Cave also believes this will change under the incoming Trump Administration and that TransDigm should be target #1 for the Department of Government Efficiency."
Musk recently took notice of a tweet from Donald Trump Jr. that highlighted Boeing allegedly overcharging the Air Force, Dorsey added.
Ramaswamy suggested that large-scale audits at government agencies like the Pentagon could yield "significant savings."
In the short report, Dorsey highlights past looks into TransDigm by Congress.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
TransDigm's Past History: The short report highlights a 2022 House Oversight Hearing on TransDigm.
"TransDigm manufactures a product called the linear actuating cap, which was used in the Eagle F-15 and C-125 transport aircraft. According to TransDigm, the part only cost $189 to make, but the company charged the Defense Department over $7,000," House Oversight Chairwoman Carolyn Maloney (D-N.Y.) said at the time.
Maloney used a graphic to illustrate the markups in aircraft parts for the Department of Defense by TransDigm, the short report added.
The short report also highlighted a 2019 hearing about TransDigm which saw Rep. Ro Khanna (D-Calif.) accuse the company of acquiring other suppliers so it can raise prices for existing customers.
"You purchased a company that made a part for $5,500, solenoid, and then after you bought it the price went up to $11,790. The part only cost $3,000. So what is the additional value when you're purchasing this and raising the price?" Khanna previously asked.
While past congressional hearings didn't find TransDigm broke the law, past concerns over price gouging could put the company on the radar of Musk and Ramaswamy as the short report said.
The defense market makes up around 40% of TransDigm's revenue, with the Department of Defense a portion of that total, the report said.
TDG Price Action: TransDigm Group stock is down 3.09% to $1,253.06 Thursday versus a 52-week trading range of $949.99 to $1,451.32. TransDigm stock is up 30% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41784498/dead-company-walking-short-seller-sets-sights-on-viasat-expects-elon-musks-starlink-to-take-share-af">&#8216;Dead Company Walking&#8217;: Short Seller Sets Sights On ViaSat, Expects Elon Musk&#8217;s Starlink To Take Share After Trump Win</a></li>
</ul>
Photos: Shutterstock

Short Ideas

Politics

Musk, Ramaswamy Should Target TransDigm In Budget Cuts, Short Report Says: 'Target #1' For D.O.G.E.

KinderCare Learning Companies shares are trading lower. The company reported Q3 financial results.

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report). The co...

Xeris Pharmaceuticals (XERS) Gets a Buy from Craig-Hallum

Xeris Pharmaceuticals Q3 2024 Earnings Preview

Here's the major earnings before the open tomorrow

Xeris Pharmaceuticals GAAP EPS of -$0.11 misses by $0.02, revenue of $54.3M beats by $2.87M

Stock Picks From Seeking Alpha's October 2024 New Analysts

Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript

Xeris Pharmaceuticals ( ($XERS) ) has released its Q3 earnings. Here is a breakdown of the information Xeris Pharmaceuticals presented to its inves...

Xeris Biopharma Reports Record Third Quarter Revenue

Piper Sandler analyst David Amsellem downgraded the rating on Xeris Pharmaceuticals (XERS – Research Report) to a Hold yesterday, setting a price t...

Xeris Pharmaceuticals: Hold Rating Amid Growth and Cost Concerns

Piper Sandler analyst David Amsellem downgraded Xeris Biopharma (XERS) to Neutral from Overweight with an unchanged price target of $3, post the Q3...

Xeris Biopharma downgraded to Neutral from Overweight at Piper Sandler

Leerink Partners analyst Roanna Ruiz maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) on November 8 and set a price target...

Xeris Pharmaceuticals: Strong Financial Performance and Strategic Growth Drive Buy Rating

ACGL

ACGLN

ACGLO

ADNT

AMCX

AMPS

AMRX

ANIP

APOG

ASOMF

ASOMY

ATSG

ATZAF

AVRE

BEPC

BHPLF

BILL

BLMN

BWXT

CBWTF

CIVI

CIVII

CIVIW

CONY

CRLBF

CRMD

CSGP

DCBO

DGEAF

DOCMF

DRMTY

FLGT

FSLR

HRTG

HUMA

ICAGY

IFRX

ILLMF

JNPR

JVTSF

LAMR

LOTBY

MSTR

OCGN

OPINL

PAGP

PARAA

PSEC

QTRHF

RCMT

REGCO

REGCP

SONY

TALK

TALKW

TGHLF

TMCWW

TSMWF

VRTX

Press Releases

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing's Syndrome Patients at ENDO 2024

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Announces CEO Succession Plan

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Xeris to Participate in Upcoming Investor Conferences

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Comments

Xeris Biopharma Holdings

Xeris Biopharma Holdings (XERS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga